These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 2898463)
21. Effect of retinoic acid on the replication of human immunodeficiency virus in HTLV-I-positive MT-4 cells. Nakashima H; Harada S; Yamamoto N Med Microbiol Immunol; 1987; 176(4):189-98. PubMed ID: 2441239 [TBL] [Abstract][Full Text] [Related]
22. Variants selected by treatment of human immunodeficiency virus-infected cells with an immunotoxin. Pincus SH; Wehrly K; Tschachler E; Hayes SF; Buller RS; Reitz M J Exp Med; 1990 Sep; 172(3):745-57. PubMed ID: 1696955 [TBL] [Abstract][Full Text] [Related]
23. Selective cytotoxicity of AIDS virus infection towards HTLV-I-transformed cell lines. Koyanagi Y; Harada S; Takahashi M; Uchino F; Yamamoto N Int J Cancer; 1985 Oct; 36(4):445-51. PubMed ID: 2995259 [TBL] [Abstract][Full Text] [Related]
24. Pseudotyping of HIV-1 with Human T-Lymphotropic Virus 1 (HTLV-1) Envelope Glycoprotein during HIV-1-HTLV-1 Coinfection Facilitates Direct HIV-1 Infection of Female Genital Epithelial Cells: Implications for Sexual Transmission of HIV-1. Tang Y; George AM; Petrechko O; Nouvet FJ; Sweet SD; Tanaka Y; Imbiakha BS; Jiang G; Gao W; Anastos K; Hildreth JEK mSphere; 2018 Apr; 3(2):. PubMed ID: 29624497 [TBL] [Abstract][Full Text] [Related]
25. Frequent partial deletion of human adult T-cell leukemia virus type I proviruses in experimental transmission: pattern and possible implication. Hiramatsu K; Yoshikura H J Virol; 1986 May; 58(2):508-12. PubMed ID: 3009864 [TBL] [Abstract][Full Text] [Related]
26. Molecular aspect on regulation of HTLV-1 replication and leukemogenesis. Yoshida M Kansenshogaku Zasshi; 1988 Mar; 62 Suppl():13-9. PubMed ID: 2901448 [No Abstract] [Full Text] [Related]
27. Cells surviving infection by human immunodeficiency virus type 1: vif or vpu mutants produce non-infectious or markedly less cytopathic viruses. Kishi M; Nishino Y; Sumiya M; Ohki K; Kimura T; Goto T; Nakai M; Kakinuma M; Ikuta K J Gen Virol; 1992 Jan; 73 ( Pt 1)():77-87. PubMed ID: 1730943 [TBL] [Abstract][Full Text] [Related]
28. Recent advances in the molecular biology of HTLV-1: trans-activation of viral and cellular genes. Yoshida M; Seiki M Annu Rev Immunol; 1987; 5():541-59. PubMed ID: 2885015 [No Abstract] [Full Text] [Related]
29. Properties of virus-like particles produced by SIV-chronically infected human cell clones. Kraiselburd EN; Torres JV Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S41-52. PubMed ID: 8574147 [TBL] [Abstract][Full Text] [Related]
30. Human retroviral env and gag polypeptides: serologic assays to measure infection. Kanner SB; Cheng-Mayer C; Geffin RB; Parks WP; Beltz GA; Arthur LO; Samuel KP; Papas TS J Immunol; 1986 Jul; 137(2):674-8. PubMed ID: 3014000 [TBL] [Abstract][Full Text] [Related]
31. Susceptibility to infection by the human immunodeficiency virus (HIV) correlates with T4 expression in a parental monocytoid cell line and its subclones. Asjö B; Ivhed I; Gidlund M; Fuerstenberg S; Fenyö EM; Nilsson K; Wigzell H Virology; 1987 Apr; 157(2):359-65. PubMed ID: 3103330 [TBL] [Abstract][Full Text] [Related]
32. The ratio of defective HIV-1 particles to replication-competent infectious virions. Bourinbaiar AS Acta Virol; 1994 Feb; 38(1):59-61. PubMed ID: 7520666 [TBL] [Abstract][Full Text] [Related]
33. Chronic production of defective-interfering particles by hamster embryo cultures of herpesvirus persistently infected and oncogenically transformed cells. Dauenhauer SA; Robinson RA; O'Callaghan DJ J Gen Virol; 1982 May; 60(Pt 1):1-14. PubMed ID: 6178795 [TBL] [Abstract][Full Text] [Related]
34. Clonal analysis of functional differences among strains of human immunodeficiency virus (HIV). Harada S; Yamamoto N; Hinuma Y J Virol Methods; 1987 Dec; 18(4):291-303. PubMed ID: 2450887 [TBL] [Abstract][Full Text] [Related]
35. Mechanisms associated with the generation of biologically active human immunodeficiency virus type 1 particles from defective proviruses. Inoue M; Hoxie JA; Reddy MV; Srinivasan A; Reddy EP Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2278-82. PubMed ID: 2006168 [TBL] [Abstract][Full Text] [Related]
36. Defective infection of rabbit peripheral blood monocyte cultures with human immunodeficiency virus type 1. Tseng CK; Leibowitz J; Sell S AIDS Res Hum Retroviruses; 1994 Mar; 10(3):285-93. PubMed ID: 8018389 [TBL] [Abstract][Full Text] [Related]
38. Superinfection of human immunodeficiency virus type 1 (HIV-1) to cell clone persistently infected with defective virus induces production of highly cytopathogenic HIV-1. Iwabu Y; Goto T; Tsuji S; Warachit J; Li GM; Shoji S; Kameoka M; Ikuta K Microbes Infect; 2006 Jun; 8(7):1773-82. PubMed ID: 16815724 [TBL] [Abstract][Full Text] [Related]
39. The role of the x gene in HTLV associated malignancy. Chen IS; Wachsman W; Rosenblatt JD; Cann AJ Cancer Surv; 1986; 5(2):329-42. PubMed ID: 2877734 [TBL] [Abstract][Full Text] [Related]
40. A biological response modifier, PSK, inhibits human immunodeficiency virus infection in vitro. Tochikura TS; Nakashima H; Hirose K; Yamamoto N Biochem Biophys Res Commun; 1987 Oct; 148(2):726-33. PubMed ID: 2825669 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]